Literature DB >> 15777236

Functional characteristic of snake venom disintegrins: potential therapeutic implication.

Cezary Marcinkiewicz1.   

Abstract

Snake venom disintegrins are the natural products that have been investigated as potent inhibitors of various integrins. Functionally, disintegrins can be divided into three groups according to their integrin selectivity and presence of specific, active motifs. This classification includes RGD-disintegrins, MLD-disintegrins, and KTS-disintegrins. RGD-disintegrins have been the most intensively investigated, and their research resulted in design and synthesis of new pharmaceutical compounds, eptifibatide and tirofiban that are currently being evaluated for the therapy of acute coronary ischaemic syndrome. MLD- and KTS-disintegrins are specific for leukocyte integrins and collagen receptors, respectively, and are being investigated in the new fields of pharmaceutical research. This review summarizes the biological activities of snake venom disintegrins, as well as discusses their potential in the study of the pharmacology of various human diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15777236     DOI: 10.2174/1381612053381765

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  23 in total

Review 1.  ADAM-17: the enzyme that does it all.

Authors:  Monika Gooz
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-04       Impact factor: 8.250

Review 2.  The Molecular Basis of Toxins' Interactions with Intracellular Signaling via Discrete Portals.

Authors:  Adi Lahiani; Ephraim Yavin; Philip Lazarovici
Journal:  Toxins (Basel)       Date:  2017-03-16       Impact factor: 4.546

3.  Acurhagin-C, an ECD disintegrin, inhibits integrin alphavbeta3-mediated human endothelial cell functions by inducing apoptosis via caspase-3 activation.

Authors:  Wen-Jeng Wang
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

4.  Isolation and Functional Identification of an Antiplatelet RGD-Containing Disintegrin from Cerastes cerastes Venom.

Authors:  Meriem Ameziani; Fatah Chérifi; Hamida Kiheli; Samah Saoud; Ghania Hariti; Safia Kellou-Taîri; Fatima Laraba-Djebari
Journal:  Protein J       Date:  2020-09-22       Impact factor: 2.371

5.  Recombinant rubistatin (r-Rub), an MVD disintegrin, inhibits cell migration and proliferation, and is a strong apoptotic inducer of the human melanoma cell line SK-Mel-28.

Authors:  Clayton M Carey; Raymund Bueno; Daniel A Gutierrez; Christopher Petro; Sara E Lucena; Elda E Sanchez; Julio G Soto
Journal:  Toxicon       Date:  2011-12-13       Impact factor: 3.033

6.  Identification of inhibitors of α2β1 integrin, members of C-lectin type proteins, in Echis sochureki venom.

Authors:  Piotr Jakubowski; Juan J Calvete; Johannes A Eble; Philip Lazarovici; Cezary Marcinkiewicz
Journal:  Toxicol Appl Pharmacol       Date:  2013-03-13       Impact factor: 4.219

7.  Integrin alpha9 beta1 is a receptor for nerve growth factor and other neurotrophins.

Authors:  Izabela Staniszewska; Ilker K Sariyer; Shimon Lecht; Meghan C Brown; Erin M Walsh; George P Tuszynski; Mahmut Safak; Philip Lazarovici; Cezary Marcinkiewicz
Journal:  J Cell Sci       Date:  2008-01-29       Impact factor: 5.285

Review 8.  Applications of snake venom components to modulate integrin activities in cell-matrix interactions.

Authors:  Cezary Marcinkiewicz
Journal:  Int J Biochem Cell Biol       Date:  2013-06-26       Impact factor: 5.085

9.  The antitumor efficacy of monomeric disintegrin obtustatin in S-180 sarcoma mouse model.

Authors:  Narine Ghazaryan; Naira Movsisyan; Joana Catarina Macedo; Sara Vaz; Naira Ayvazyan; Luis Pardo; Elsa Logarinho
Journal:  Invest New Drugs       Date:  2019-01-25       Impact factor: 3.850

10.  Structure of acostatin, a dimeric disintegrin from Southern copperhead (Agkistrodon contortrix contortrix), at 1.7 A resolution.

Authors:  Natalia Moiseeva; Robert Bau; Stephen D Swenson; Francis S Markland; Jun Yong Choe; Zhi Jie Liu; Marc Allaire
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2008-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.